Alyeska Investment Group

Alyeska Investment Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Alyeska Investment Group’s Portfolio CDAK Stock Details CDAK Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$265K	Sell
2022 Q3	$573K	Buy
2021 Q2	–	Sell
2021 Q1	$902K	Hold
2020 Q4	$1.93M	Buy